Neurogene Inc (NGNE)
36.40
+1.58
(+4.54%)
USD |
NASDAQ |
Jun 28, 16:00
36.40
0.00 (0.00%)
After-Hours: 20:00
Neurogene Free Cash Flow: -59.87M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -59.87M |
Free Cash Flow Range, Past 5 Years
-59.87M
Minimum
Mar 2024
-59.87M
Maximum
Mar 2024
-59.87M
Average
-59.87M
Median
Mar 2024
Free Cash Flow Benchmarks
| Taysha Gene Therapies Inc | -76.24M |
| CEL-SCI Corp | -20.40M |
| AIM ImmunoTech Inc | -23.04M |
| IGC Pharma Inc | -5.714M |
| NovaBay Pharmaceuticals Inc | -4.524M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.65M |
| Cash from Investing (Quarterly) | 29.94M |
| Cash from Financing (Quarterly) | -6.524M |
| Free Cash Flow Per Share (Quarterly) | -1.285 |
| Free Cash Flow Yield | -30.85% |